Pomaglumetad methionil structure
|
Common Name | Pomaglumetad methionil | ||
---|---|---|---|---|
CAS Number | 956385-05-0 | Molecular Weight | 384.42600 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C12H20N2O8S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Pomaglumetad methionilPomaglumetad methionil (LY2140023 hydrate) is an oral methionine prodrug of the potent specific mGlu2/3 receptor agonist LY404039 (HY-50906). Pomaglumetad methionil is well-tolerated and has a distinct safety profile, and can be used to treat schizophrenia[1][2]. |
Name | (1R,4S,5S,6S)-4-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-2,2-dioxo-2λ6-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid,hydrate |
---|---|
Synonym | More Synonyms |
Description | Pomaglumetad methionil (LY2140023 hydrate) is an oral methionine prodrug of the potent specific mGlu2/3 receptor agonist LY404039 (HY-50906). Pomaglumetad methionil is well-tolerated and has a distinct safety profile, and can be used to treat schizophrenia[1][2]. |
---|---|
Related Catalog | |
Target |
mGlu2/3 receptor[1][2] |
References |
Molecular Formula | C12H20N2O8S2 |
---|---|
Molecular Weight | 384.42600 |
Exact Mass | 384.06600 |
PSA | 210.26000 |
LogP | 0.69110 |
Pomaglumetad methionil |
UNII-WE665JB15R |